<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000392.v1.p1" parentStudy="phs000392.v1.p1" createDate="2011-08-05" modDate="2012-03-26">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Tadafumi Kato, MD, PhD</td><td>RIKEN Brain Science Institute, Saitama, Japan</td></tr>
		<tr><td>Funding Source</td><td>RIKEN Brain Science Institute Funds</td><td>RIKEN Brain Science Institute, Saitama, Japan</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Exome Sequencing of arPEO</StudyNameEntrez>
	<StudyNameReportPage>Exome sequencing of autosomal recessive progressive external ophthalmoplegia (arPEO)</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Exome Sequencing</StudyType>
		<StudyType>Single Patient</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>Progressive external ophthalmoplegia (PEO) is an inherited mitochondrial disease that follows either autosomal dominant or recessive forms of inheritance (adPEO or arPEO). AdPEO is a genetically heterogeneous disease and several genes including <i>POLG1</i> and <i>C10orf2</i>/Twinkle have been identified as responsible genes. On the other hand, <i>POLG1</i> was the only established gene causing arPEO with mitochondrial DNA deletions. We previously reported a case of PEO with unidentified genetic etiology. The patient was born of a first-cousin marriage. Therefore, the recessive form of inheritance was suspected. To identify the disease causing variant in this patient, we subjected the patient&#39;s DNA to whole-exome sequencing and narrowed down the candidate variants using public data and runs of homozygosity analysis.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Single case of progressive external ophthalmoplegia was included.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="21951382"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Ophthalmoplegia, Chronic Progressive External"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Tadafumi Kato, MD, PhD</AttName>
			<Institution>RIKEN Brain Science Institute, Saitama, Japan</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>RIKEN Brain Science Institute Funds</AttName>
			<Institution>RIKEN Brain Science Institute, Saitama, Japan</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHGRI</DacName>
      <DacFullName>National Human Genome Research Institute</DacFullName>
      <DacEmail>nhgridac@mail.nih.gov</DacEmail>
      <DacPhone></DacPhone>
      <DacFax>301-480-2770</DacFax>
      <DacUrl>http://grants.nih.gov/grants/gwas</DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000392.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
               http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000392.v1.p1
            </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000392.v1.p1" FileName="KATO_DUC_FINAL.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>The data will only be used for research purposes.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
